The EU Commission fines a pharmaceutical company €7.5M for providing inaccurate information during review of an acquisition application (Merck / Sigma-Aldrich)

On 3 May 2021, the EC fined Sigma-Aldrich EUR 7.5 million for providing incorrect or misleading information during the EC’s review of Merck’s planned acquisition of the company. Background On 21 April 2015, Merck notified the EC of its plan to acquire Sigma-Aldrich. On 15 June 2015, the EC approved the proposed acquisition subject to the divestiture of certain Sigma-Aldrich assets, which would address the competition concerns identified in markets for specific laboratory chemicals (Decision C (2015) 4188 final of 15 June 2015 in Case M.7435, Merck/Sigma-Aldrich). During the course of the divestment process, the EC became aware of a Sigma-Aldrich innovation

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteurs

  • McDermott Will & Emery (Paris)
  • McDermott Will & Emery (Washington)

Citation

Frédéric Pradelles, Mary Hecht, The EU Commission fines a pharmaceutical company €7.5M for providing inaccurate information during review of an acquisition application (Merck / Sigma-Aldrich), 3 mai 2021, e-Competitions May 2021, Art. N° 106714

Visites 82

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues